MedTrace Logo

WHOOP ECG Software Performance Assessment Study

NCT06622265 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 540

Last updated 2024-10-02

No results posted yet for this study

Summary

The purpose of the study is to evaluate the performance of ECG classification algorithms and their ability to classify heart rhythms into multiple categories of rhythms and heart rates.

Conditions

  • Atrial Fibrillation (AF)

Interventions

DEVICE

Electrocardiogram recording

ECG recording with investigational device

Sponsors & Collaborators

  • Whoop Inc.

    lead INDUSTRY

Principal Investigators

  • Gerald Early, M.D. · Iqvia Pty Ltd

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-15
Primary Completion
2024-07-03
Completion
2024-07-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06622265 on ClinicalTrials.gov